Solta Medical (Reliant)mature on its arc

Solta Medical (Reliant) Fraxel Dual 1550/1927
used resale value & depreciation report

Non-ablative Fractional · launched 2008 · Steady demand
$20,900used median
17%of new retained
$120,000new (MSRP)
Steadycategory demand

Where the Solta Medical (Reliant) Fraxel Dual 1550/1927 stands on the used market

  • Hard depreciator: only about 17% of its ~$120,000 new price survives to the used market — new, expensive, and sliding, the rep's favorite upsell.
  • At 18 years (launched 2008) it is a veteran platform; age alone is not a reason to replace it — service, consumables and maker support are.
  • Category demand is steady — priced inside the band, it trades at a normal pace.
  • Status note: coined "fractional" (Fraxel 2004). Maker servicing / software-lock status affects whole-unit resale — parts may be the realistic path.

A new unit depreciates hard the day it ships — the single best reason not to finance one.

Resale & market facts

New (MSRP)$120,000
Used median$20,900
Fair resale band$13,600 – $28,094
Value retained vs new17%
Live comps4 · Medium liquidity
CategoryNon-ablative Fractional
Energy / modalityfractional
Wavelength1550/1927 nm
Chromophore (target)water
Treatspigment, texture, melasma
Demand trendSteady
Segment demandEnergy-based (broad) · ~10%/yr
Launched2008
In service18 years
Lifecycle arcMature

Sell now, or wait? Projected resale for the Solta Medical (Reliant) Fraxel Dual 1550/1927

2026
$20,900
today
→
2027
$19,800
1 yr
→
2029
$18,000
3 yr
→
2031
$16,600
5 yr

Our model projects the Solta Medical (Reliant) Fraxel Dual 1550/1927 loses about 21% of today's resale over five years (~11%/yr toward a $11,200 salvage floor), modulated by steady category demand (Energy-based (broad) ~10%/yr). Priced right, there is little upside to holding.

What a dead or retired Solta Medical (Reliant) Fraxel Dual 1550/1927 is worth

Even non-working, a Solta Medical (Reliant) Fraxel Dual 1550/1927 is rarely worthless. It is a handpiece-rich device, so the recoverable parts — handpieces, optics and power supply — run roughly $7,300–$10,050. A rep who takes it for "$0 trade credit" on a new box is quietly pocketing that value — get the real number first.

Solta Medical (Reliant) Fraxel Dual 1550/1927 — common questions

What is a used Solta Medical (Reliant) Fraxel Dual 1550/1927 worth?
A used Solta Medical (Reliant) Fraxel Dual 1550/1927 sells for roughly $20,900 (median of live asking-price comps), typically $10,000–$31,376 depending on condition, hours and configuration. That is about 17% of its ~$120,000 new price. Asking prices, not confirmed sold prices.
How much does a Solta Medical (Reliant) Fraxel Dual 1550/1927 depreciate?
Our model projects a used Solta Medical (Reliant) Fraxel Dual 1550/1927 loses about 21% of today's resale over five years (~11%/yr), drifting toward a $11,200 salvage floor: $20,900 today → $19,800 in a year → $18,000 in three → $16,600 in five.
Should I trade in my Solta Medical (Reliant) Fraxel Dual 1550/1927 on a new one?
Usually the trade-in credit a rep offers is far below the open-market resale, because they resell or scrap it and keep the spread. A used Solta Medical (Reliant) Fraxel Dual 1550/1927 holds about 17% of its new value; sell it on the open market and you keep that spread instead of handing it over to finance a new box.
What is a dead or retired Solta Medical (Reliant) Fraxel Dual 1550/1927 worth?
Even non-working, a Solta Medical (Reliant) Fraxel Dual 1550/1927 is rarely worthless: the recoverable parts (handpieces, optics and power supply) run about $7,300–$10,050. Don't let a rep take it for $0 trade credit and dumpster it.
The number the rep won't show you

Value your exact Solta Medical (Reliant) — free.

Run the independent Device Atlas on your own unit: fair resale today, how fast it sells, the sell-now-vs-wait math, and what it's worth even dead. We sell no hardware.

Value my Solta Medical (Reliant) device → Browse every device
Independent by design. Alvea sells no aesthetic hardware — so this report has no reason to push you toward a purchase, a trade-in, or a financing deal. It reads the market, not your patients. This is equipment resale and market intelligence, not clinical guidance. Figures are live asking-price comps (asking ≠ sold); new MSRP and launch years are approximate.